{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T05:09:02Z","timestamp":1721452142669},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,3]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>The purpose of this review is to provide insight on the proposed association between crystal arthritis and bone health. Crystal arthritis is the most common type of inflammatory arthritis, and fractures contribute to significant morbidity and mortality, therefore, the relationship between the two is of clinical importance.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>There have been variable findings regarding hyperuricemia, low bone density and risk of fracture. A recent systematic review and meta-analysis of available literature showed a correlation between increased serum uric acid and lower risk of fracture. Less is known about calcium pyrophosphate deposition disease and bone health, although two large studies have suggested an association with osteopenia.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>A systematic review and meta-analysis of available data suggest a correlation between increased serum uric acid and lower risk of fracture. Findings support an association between bone health and crystal arthritis which warrants further study and may have implications for how we treat gout.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/bor.0000000000000469","type":"journal-article","created":{"date-parts":[[2017,11,30]],"date-time":"2017-11-30T18:38:21Z","timestamp":1512067101000},"page":"173-176","source":"Crossref","is-referenced-by-count":1,"title":["Crystalline arthropathy and bone health"],"prefix":"10.1097","volume":"30","author":[{"given":"Ian","family":"Chang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Gazeley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230928","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/eci.12677","article-title":"Hyperuricemia protects against low bone mineral density, osteoporosis and fractures: a systematic review and meta-analysis","volume":"46","author":"Veronese","year":"2016","journal-title":"Eur J Clin Invest"},{"key":"R2-20230928","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.2174\/138161205774913255","article-title":"Uric acid and oxidative stress","volume":"11","author":"Glantzounis","year":"2005","journal-title":"Curr Pharm Des"},{"key":"R3-20230928","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1007\/s00198-017-4059-3","article-title":"The association between serum uric acid level and the risk of fractures: a systematic review and meta-analysis","volume":"28","author":"Yin","year":"2017","journal-title":"Osteoporos Int"},{"key":"R4-20230928","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/jbmr.286","article-title":"Serum uric acid is associated with bone health in older men: a cross-sectional population-based study","volume":"26","author":"Nabipour","year":"2011","journal-title":"J Bone Miner Res"},{"key":"R5-20230928","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/jbmr.2164","article-title":"Osteoporotic Fractures in Men Study Group. Association of serum uric acid and incident nonspine fractures in elderly men: the Osteoporotic Fractures in Men (MrOS) Study","volume":"29","author":"Lane","year":"2014","journal-title":"J Bone Miner Res"},{"key":"R6-20230928","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1007\/s00198-014-2697-2","article-title":"Higher serum uric acid as a protective factor against incident osteoporotic fractures in Korean men: a longitudinal study using the National Claim Registry","volume":"25","author":"Kim","year":"2014","journal-title":"Osteoporos Int"},{"key":"R7-20230928","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1007\/s00198-013-2377-7","article-title":"Higher serum uric acid is associated with higher bone mass, lower bone turnover, and lower prevalence of vertebral fracture in healthy postmenopausal women","volume":"24","author":"Ahn","year":"2013","journal-title":"Osteoporos Int"},{"key":"R8-20230928","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/art.39852","article-title":"Gout and risk of fracture in women: a prospective cohort study","volume":"69","author":"Paik","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"R9-20230928","doi-asserted-by":"crossref","first-page":"e4669","DOI":"10.1097\/MD.0000000000004669","article-title":"Gout increases risk of fracture: a nationwide population-based cohort study","volume":"95","author":"Tzeng","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"R10-20230928","doi-asserted-by":"crossref","first-page":"R56","DOI":"10.1186\/ar3769","article-title":"The independent association between parathyroid hormone levels and hyperuricemia: a national population study","volume":"14","author":"Hui","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"R11-20230928","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.metabol.2013.09.018","article-title":"Uric acid suppresses 1 alpha hydroxylase in vitro and in vivo","volume":"63","author":"Chen","year":"2014","journal-title":"Metabolism"},{"key":"R12-20230928","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1136\/ard.2010.144774","article-title":"Monosodium urate monohydrate crystals inhibit osteoblast viability and function: implications for development of bone erosion in gout","volume":"70","author":"Chhana","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R13-20230928","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3892\/ijmm.2017.2876","article-title":"Melittin inhibits osteoclast formation through the downregulation of the RANKL-RANK signaling pathway and the inhibition of the interleukin- 1B in murine macrophages","volume":"39","author":"Choe","year":"2017","journal-title":"Int J Mol Med"},{"key":"R14-20230928","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.orthres.2004.11.014","article-title":"Colchicine inhibits fracture union and reduces bone strength: in vivo study","volume":"23","author":"Dudkiewicz","year":"2005","journal-title":"J Orthop Res"},{"key":"R15-20230928","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.yexcr.2016.03.004","article-title":"Allopurinol and oxypurinol promote osteoblast differentiation and increase bone formation","volume":"342","author":"Orriss","year":"2016","journal-title":"Exp Cell Res"},{"key":"R16-20230928","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1136\/annrheumdis-2013-203400","article-title":"Association between low cortical bone mineral density, soft-tissue calcification, vascular calcification and chondrocalcinosis: a case-control study","volume":"73","author":"Abhishek","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"R17-20230928","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/acr.23160","article-title":"Calcium pyrophosphate deposition disease and associated medical comorbidities: a National Cross-Sectional Study of US Veterans","volume":"69","author":"Kleiber Balderrama","year":"2017","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R18-20230928","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1136\/ard.2008.099531","article-title":"High systematic bone mineral density increases the risk of incident knee OA and joint space narrowing, but not radiographic progression of existing knee OA: the MOST study","volume":"69","author":"Nevitt","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"R19-20230928","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/00003086-197505000-00038","article-title":"Pyrophosphate and diphosphonates in skeletal metabolism. Clinical orthopaedics and related research","volume":"108","author":"Russell","year":"1975","journal-title":"Clin Orthop Relat Res"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00002281-201803000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T02:04:11Z","timestamp":1695866651000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002281-201803000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000469","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3]]}}}